The global business landscape is entering a new era of mega-mergers and acquisitions, with companies increasingly turning to large deals to gain scale, access new markets, secure technology and strengthen their competitive position.
Global M&A activity reached record levels in the first half of 2026. According to LSEG data reported by Reuters, announced deals were worth about $2.8 trillion between January and June, representing a 48 per cent increase from the same period in 2025. Although the number of deals declined, transactions worth more than $10 billion accounted for almost half of total deal value.
PwC expects global M&A value to approach $4 trillion in 2026, with deals above $5 billion accounting for nearly half of the market. The trend shows that while fewer companies are completing acquisitions, the deals that do happen are becoming significantly larger.
Energy has emerged as one of the major areas of activity. NextEra Energy’s proposed $66.8 billion merger with Dominion Energy is among the year’s biggest transactions, reflecting the growing importance of electricity infrastructure as economies invest heavily in power generation and the infrastructure needed to support artificial intelligence.
Technology is another major driver. Companies and investors are searching for assets that can give them an advantage in artificial intelligence, cloud computing and digital infrastructure. The growing demand for data centres and computing capacity has made technology and energy assets increasingly attractive to large investors.
Healthcare is also seeing major transactions. In July, Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for about $9.8 billion, while Eli Lilly agreed to acquire AtaiBeckley in a deal worth up to $3.8 billion. The transactions highlight the pharmaceutical industry’s continued push to strengthen drug pipelines through acquisitions.
Banking is another sector being reshaped by consolidation. UniCredit’s proposed €43 billion takeover of Commerzbank could become the largest European bank merger since the global financial crisis if it receives the necessary approvals. The deal has attracted attention because of its potential impact on Germany’s banking sector and wider European financial integration.
Not every mega-deal, however, is guaranteed to succeed. A proposed merger between AstraZeneca and Bristol Myers Squibb that could have created a pharmaceutical giant worth almost $400 billion collapsed in August after investors raised concerns about the strategic fit, regulatory risks and future growth prospects.
The changing M&A landscape shows that size alone is no longer enough. Companies must demonstrate that a deal can produce long-term value, improve competitiveness and survive regulatory and shareholder scrutiny.
For global businesses, the message is clear: mergers and acquisitions are becoming bigger, more strategic and increasingly influenced by artificial intelligence, energy security, healthcare innovation and the race for global scale.
